Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 17Thoracic 2Genitourinary 2Gastrointestinal 2Other solid neoplasm 1

Conditions

Mesothelioma 13Mesothelioma, Malignant 7Carcinoma, Non-Small-Cell Lung 5Solid Tumor 4Ovarian Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumor, Adult 2Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Lung Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Merkel Cell 2Turcot syndrome 1Skin Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Microsatellite Unstable Colorectal Cancer 1Metastatic Solid Tumors 1Liver Neoplasms 1Kidney Neoplasms 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1

Interventions

pembrolizumab 3Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Ipilimumab 1Interleukin-2 1Immunotherapy 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Ipilimumab × Other solid neoplasm × Clear all
NCT06362369 2026-04-13

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

7 Hills Pharma, LLC

Phase 1/2 Recruiting
126 enrolled
DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Turcot syndrome, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡